Search
for

    Sort by

    Research 361–390 of 1000+

    1. Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in presence of finasteride degradation product Acta Chromatographica · 2019 · 4 citations
    2. Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma Case reports in endocrinology · 2018 · 4 citations
    3. Pathology in Practice Javma-journal of The American Veterinary Medical Association · 2014 · 4 citations
    4. Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis. Urology Journal · 2020 · 3 citations
    5. Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin Experimental and Therapeutic Medicine · 2018 · 3 citations
    6. Effects of Guasha on histomorphology of scraped skins and on expression of calcitonin gene-related peptide and substance P in rats Deleted Journal · 2018 · 3 citations
    7. Simultaneous Estimation of Finasteride and Tamsulosin Hydrochloride in Combined Dosage Forms by RP-HPLC-PDA Method 2012 · 3 citations
    8. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS 2019 · 2 citations
    9. Should Finasteride Be Routinely Given Preoperatively for TURP? ISRN Urology (Print) · 2013 · 2 citations
    10. UV SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS DETERMINATION OF FINASTERIDE AND TAMSULOSIN IN COMBINED DOSAGE FORM 2011 · 2 citations
    11. Treatment of female sexual dysfunction in postmenopausal women—What is the evidence? Reviews in Gynaecological Practice · 2004 · 2 citations
    12. The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia Journal of Cosmetic Dermatology · 2018 · 1 citations
    13. Telogen hair loss and androgenetic‐like alopecia in GAPO syndrome Australasian Journal of Dermatology · 2018 · 1 citations
    14. Antihelminthic Drugs Side effects of drugs annual · 2014 · 1 citations
    15. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    16. DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT International Journal of Applied Pharmaceutics · 2026
    17. Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats Global Translational Medicine · 2026
    18. Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system Frontiers in Medicine · 2026
    19. Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review International Journal of Social health · 2025
    20. African Journal of Biomedical Research 2025
    21. Simultaneous Quantification of Dutasteride and Silodosin Using a Stability-Indicating RP-HPLC Approach International Journal of Pharmaceutical Quality Assurance · 2024
    22. Inhibitory Effects of Pueraria mirifica Aqueous Extracts on 5α-reductase and Prostate Histomorphometry in Testosterone-induced Benign Prostatic Hyperplasia Sprague Dawley Rats 2023
    23. 5α- Reductase Inhibitors in Prostate Cancer: An Overview Austin Journal of Cancer and Clinical Research · 2017
    24. Hair loss at 20 associated with prostate cancer risk later in life Cancer · 2011
    25. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010
    26. Update on medical management of benign prostatic hyperplasia UK vet. Companion animal · 2008
    27. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    28. Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses Nature Clinical Practice Urology · 2007
    29. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    30. Supplements That May Counteract Side Effects from Conventional Cancer Therapies 2006